FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes
Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.